Search research articles
Contact Us
Filters
Showing results (1-10 of 54) with videos related to
Page
of 6
Sort By:
Expert Opinion on Therapeutic Targets
|
July 9, 2013
CD8(+) T cells in multiple sclerosis
Aleksandar Denic, Bharath Wootla, Moses Rodriguez
Methods in Molecular Biology (Clifton, N.J.)
|
September 17, 2013
Polyclonal and monoclonal antibodies in clinic
Bharath Wootla, Aleksandar Denic, Moses Rodriguez
Autoimmune Diseases
|
June 6, 2012
Is multiple sclerosis an autoimmune disease?
Bharath Wootla, Makoto Eriguchi, Moses Rodriguez
Current Pharmaceutical Design
|
September 17, 2016
Multiple Sclerosis, Gut Microbiota and Permeability: Role of Tryptophan Catabolites, Depression and the Driving Down of Local Melatonin
Moses Rodriguez, Bharath Wootla, George Anderson
Current Pharmaceutical Design
|
December 16, 2015
Tryptophan Metabolites and Their Impact on Multiple Sclerosis Progression
Jens O Watzlawik, Bharath Wootla, Moses Rodriguez
Current Pharmaceutical Design
|
February 23, 2016
Tryptophan Catabolites and Their Impact on Multiple Sclerosis Progression
Jens O Watzlawik, Bharath Wootla, Moses Rodriguez
Journal of Neurology & Translational Neuroscience
|
November 11, 2014
Deletion of Virus-specific T-cells Enhances Remyelination in a Model of Multiple Sclerosis
Aleksandar Denic, Bharath Wootla, Laurie Zoecklein, et al.
Expert Review of Clinical Immunology
|
June 5, 2013
The road to remyelination in demyelinating diseases: current status and prospects for clinical treatment
Bharath Wootla, Jens O Watzlawik, Aleksandar Denic, et al.
Journal of Neuroinflammation
|
April 30, 2016
A monoclonal natural human IgM protects axons in the absence of remyelination
Bharath Wootla, Aleksandar Denic, Arthur E Warrington, et al.
International Journal of Physical Medicine & Rehabilitation
|
September 6, 2016
Concomitant Use of Neuroprotective Drugs in Neuro Rehabilitation of Multiple Sclerosis
Harika Dasari, Bharath Wootla, Arthur E Warrington, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 54) with videos related to
Sort By:
Page
of 6
Expert Opinion on Therapeutic Targets
|
July 9, 2013
CD8(+) T cells in multiple sclerosis
Aleksandar Denic, Bharath Wootla, Moses Rodriguez
Methods in Molecular Biology (Clifton, N.J.)
|
September 17, 2013
Polyclonal and monoclonal antibodies in clinic
Bharath Wootla, Aleksandar Denic, Moses Rodriguez
Autoimmune Diseases
|
June 6, 2012
Is multiple sclerosis an autoimmune disease?
Bharath Wootla, Makoto Eriguchi, Moses Rodriguez
Current Pharmaceutical Design
|
September 17, 2016
Multiple Sclerosis, Gut Microbiota and Permeability: Role of Tryptophan Catabolites, Depression and the Driving Down of Local Melatonin
Moses Rodriguez, Bharath Wootla, George Anderson
Current Pharmaceutical Design
|
December 16, 2015
Tryptophan Metabolites and Their Impact on Multiple Sclerosis Progression
Jens O Watzlawik, Bharath Wootla, Moses Rodriguez
Current Pharmaceutical Design
|
February 23, 2016
Tryptophan Catabolites and Their Impact on Multiple Sclerosis Progression
Jens O Watzlawik, Bharath Wootla, Moses Rodriguez
Journal of Neurology & Translational Neuroscience
|
November 11, 2014
Deletion of Virus-specific T-cells Enhances Remyelination in a Model of Multiple Sclerosis
Aleksandar Denic, Bharath Wootla, Laurie Zoecklein, et al.
Expert Review of Clinical Immunology
|
June 5, 2013
The road to remyelination in demyelinating diseases: current status and prospects for clinical treatment
Bharath Wootla, Jens O Watzlawik, Aleksandar Denic, et al.
Journal of Neuroinflammation
|
April 30, 2016
A monoclonal natural human IgM protects axons in the absence of remyelination
Bharath Wootla, Aleksandar Denic, Arthur E Warrington, et al.
International Journal of Physical Medicine & Rehabilitation
|
September 6, 2016
Concomitant Use of Neuroprotective Drugs in Neuro Rehabilitation of Multiple Sclerosis
Harika Dasari, Bharath Wootla, Arthur E Warrington, et al.
Page
of 6